In this work, we present the synthesis and evaluation of magnetic resonance (MR) properties of novel phosphorus/iron-containing probes for dual 31P and 1H MR imaging and spectroscopy (MRI and MRS). The presented probes are composed of biocompatible semitelechelic and multivalent phospho-polymers based on poly(2-methacryloyloxyethyl phosphorylcholine) (pMPC) coordinated with small paramagnetic Fe3+ ions or superparamagnetic maghemite (γ-Fe2O3) nanoparticles via deferoxamine group linked to the end or along the polymer chains. All probes provided very short 1H T1 and T2 relaxation times even at low iron concentrations. The presence of iron had a significant impact on the shortening of 31P relaxation, with the effect being more pronounced for probes based on γ-Fe2O3 and multivalent polymer. While the water-soluble probe having one Fe3+ ion per polymer chain was satisfactorily visualized by both 31P-MRS and 31P-MRI, the probe with multiple Fe3+ ions could only be detected by 31P-MRS, and the probes consisting of γ-Fe2O3 nanoparticles could not be imaged by either technique due to their ultra-short 31P relaxations. In this proof-of-principle study performed on phantoms at a clinically relevant magnetic fields, we demonstrated how the different forms and concentrations of iron affect both the 1H MR signal of the surrounding water molecules and the 31P MR signal of the phospho-polymer probe. Thus, this double contrast can be exploited to simultaneously visualize body anatomy and monitor probe biodistribution.

Faculty of Chemical Technology University of Chemistry and Technology Prague Technická 5 166 28 Prague 6 Czech Republic

Faculty of Health Studies Technical University of Liberec Studentská 1402 2 46117 Liberec Czech Republic

Institute for Clinical and Experimental Medicine Vídeňská 1958 9 140 21 Prague 4 Czech Republic

Institute of Biophysics and Informatics 1st Faculty of Medicine Charles University Kateřinská 1660 32 121 08 Prague Czech Republic

Institute of Macromolecular Chemistry Czech Academy of Sciences Heyrovského nám 2 162 00 Prague 6 Czech Republic

See more in PubMed

Jirák D, Vítek F. Basics of Medical Physics. Karolinum Press; 2017.

Wahsner J, Gale EM, Rodriguez-Rodriguez A, Caravan P. Chemistry of MRI contrast agents: Current challenges and new frontiers. Chem. Rev. 2019;119:957–1057. doi: 10.1021/acs.chemrev.8b00363. PubMed DOI PMC

Fatima A, et al. Recent advances in gadolinium based contrast agents for bioimaging applications. Nanomaterials (Basel) 2021 doi: 10.3390/nano11092449. PubMed DOI PMC

Rogosnitzky M, Branch S. Gadolinium-based contrast agent toxicity: A review of known and proposed mechanisms. Biometals. 2016;29:365–376. doi: 10.1007/s10534-016-9931-7. PubMed DOI PMC

Dulinska-Litewka J, et al. Superparamagnetic iron oxide nanoparticles-current and prospective medical applications. Materials (Basel) 2019 doi: 10.3390/ma12040617. PubMed DOI PMC

Saudek F, et al. Magnetic resonance imaging of pancreatic islets transplanted into the liver in humans. Transplantation. 2010;90:1602–1606. doi: 10.1097/TP.0b013e3181ffba5e. PubMed DOI

Patil S, Jirák D, Saudek F, Hájek M, Scheffler K. Positive contrast visualization of SPIO-labeled pancreatic islets using echo-dephased steady-state free precession. Eur. Radiol. 2011;21:214–220. doi: 10.1007/s00330-010-1909-1. PubMed DOI

Deligianni X, et al. In vivo visualization of cells labeled with superparamagnetic iron oxides by a sub-millisecond gradient echo sequence. Magn. Reson. Mater. Phys. 2014;27:329–337. doi: 10.1007/s10334-013-0422-3. PubMed DOI

Babic M, et al. Poly(L-lysine)-modified iron oxide nanoparticles for stem cell labeling. Bioconjug. Chem. 2008;19:740–750. doi: 10.1021/bc700410z. PubMed DOI

Wang R, et al. A class of water-soluble Fe(iii) coordination complexes as T1-weighted MRI contrast agents. J. Mater. Chem. B. 2021;9:1787–1791. doi: 10.1039/d0tb02716b. PubMed DOI

Palagi L, et al. Fe(deferasirox): An Iron(III)-based magnetic resonance imaging T1 contrast agent endowed with remarkable molecular and functional characteristics. J. Am. Chem. Soc. 2021;143:14178–14188. doi: 10.1021/jacs.1c04963. PubMed DOI

Marasini R, Rayamajhi S, Moreno-Sanchez A, Aryal S. Iron(iii) chelated paramagnetic polymeric nanoparticle formulation as a next-generation T1-weighted MRI contrast agent. RSC Adv. 2021;11:32216–32226. doi: 10.1039/d1ra05544e. PubMed DOI PMC

Hu R, et al. X-nuclei imaging: Current state, technical challenges, and future directions. J. Magn. Reson. Imaging. 2020;51:355–376. doi: 10.1002/jmri.26780. PubMed DOI

Liu YC, Gu YN, Yu X. Assessing tissue metabolism by phosphorous-31 magnetic resonance spectroscopy and imaging: A methodology review. Quant. Imaging Med. Surg. 2017;7:707–726. doi: 10.21037/qims.2017.11.03. PubMed DOI PMC

Neeman M, Rushkin E, Kaye AM, Degani H. 31P-NMR studies of phosphate transfer rates in T47D human breast cancer cells. Biochim. Biophys. Acta. 1987;930:179–192. doi: 10.1016/0167-4889(87)90030-9. PubMed DOI

Levine SR, et al. Human focal cerebral ischemia: Evaluation of brain pH and energy metabolism with P-31 NMR spectroscopy. Radiology. 1992;185:537–544. doi: 10.1148/radiology.185.2.1410369. PubMed DOI

Kracikova L, et al. Phosphorus-containing polymers as sensitive biocompatible probes for (31)P magnetic resonance. Molecules. 2023 doi: 10.3390/molecules28052334. PubMed DOI PMC

Kracikova L, et al. Phosphorus-containing polymeric Zwitterion: A pioneering bioresponsive probe for (31) P-magnetic resonance imaging. Macromol. Biosci. 2022;22:e2100523. doi: 10.1002/mabi.202100523. PubMed DOI

Ziolkowska N, Vit M, Laga R, Jirak D. Iron-doped calcium phytate nanoparticles as a bio-responsive contrast agent in (1)H/(31)P magnetic resonance imaging. Sci. Rep. 2022;12:2118. doi: 10.1038/s41598-022-06125-7. PubMed DOI PMC

Pechrova Z, Lobaz V, Konefał M, Konefał R, Hruby M. Colloidal probe based on iron(III)-doped calcium phytate nanoparticles for 31P NMR monitoring of bacterial siderophores. Colloid Interface Sci. Commun. 2021;42:100427. doi: 10.1016/j.colcom.2021.100427. DOI

Andrianov AK. Water-soluble polyphosphazenes for biomedical applications. J. Inorg. Organomet. Polym. Mater. 2006;16:397–406. doi: 10.1007/s10904-006-9065-4. DOI

Pelosi C, Tinè MR, Wurm FR. Main-chain water-soluble polyphosphoesters: Multi-functional polymers as degradable PEG-alternatives for biomedical applications. Eur. Polym. J. 2020 doi: 10.1016/j.eurpolymj.2020.110079. DOI

Kojima C, et al. Different antifouling effects of random and block copolymers comprising 2-methacryloyloxyethyl phosphorylcholine and dodecyl methacrylate. Eur. Polym. J. 2020 doi: 10.1016/j.eurpolymj.2020.109932. DOI

Goda T, Ishihara K, Miyahara Y. Critical update on 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer science. J. Appl. Polym. Sci. 2015 doi: 10.1002/app.41766. DOI

Subr V, Ulbrich K. Synthesis and properties of new N-(2-hydroxypropyl)-methacrylamide copolymers containing thiazolidine-2-thione reactive groups. React. Funct. Polym. 2006;66:1525–1538. doi: 10.1016/j.reactfunctpolym.2006.05.002. DOI

Subr V, Kostka L, Strohalm J, Etrych T, Ulbrich K. Synthesis of Well-Defined Semitelechelic Poly[N-(2-hydroxypropyl)methacrylamide] Polymers with Functional Group at the α-End of the Polymer Chain by RAFT Polymerization. Macromolecules. 2013;46:2100–2108. doi: 10.1021/ma400042u. DOI

Kracíková L, et al. Polymer-colloidal systems as MRI-detectable nanocarriers for peptide vaccine delivery. Eur. Polym. J. 2022 doi: 10.1016/j.eurpolymj.2022.111704. DOI

Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J. Control Release. 2000;65:271–284. doi: 10.1016/s0168-3659(99)00248-5. PubMed DOI

Schupp T, Waldmeier U, Divers M. Biosynthesis of desferrioxamine-B in Streptomyces-Pilosus—Evidence for the involvement of lysine decarboxylase. Fems Microbiol. Lett. 1987;42:135–139. doi: 10.1111/j.1574-6968.1987.tb02060.x. DOI

Evers A, Hancock RD, Martell AE, Motekaitis RJ. Metal ion recognition in ligands with negatively charged oxygen donor groups. Complexation of iron(III), gallium(III), indium(III), aluminum(III), and other highly charged metal ions. Inorg. Chem. 1989;28:2189–2195. doi: 10.1021/ic00310a035. DOI

Aaseth, J., Crisponi, G. & Andersen, O. Chelation Therapy in the Treatment of Metal Intoxication. Chelation Therapy in the Treatment of Metal Intoxication, 1–371. 10.1016/C2014-0-01302-0 (2016).

Vangijzegem T, et al. Superparamagnetic iron oxide nanoparticles (SPION): From fundamentals to state-of-the-art innovative applications for cancer therapy. Pharmaceutics. 2023 doi: 10.3390/pharmaceutics15010236. PubMed DOI PMC

Babic M, et al. Poly(N, N-dimethylacrylamide)-coated maghemite nanoparticles for stem cell labeling. Bioconjug. Chem. 2009;20:283–294. doi: 10.1021/bc800373x. PubMed DOI

Laurent S, et al. Magnetic iron oxide nanoparticles: Synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev. 2008;108:2064–2110. doi: 10.1021/cr068445e. PubMed DOI

Pollert E, et al. Magnetic poly(glycidyl methacrylate) microspheres containing maghemite prepared by emulsion polymerization. J. Magn. Magn. Mater. 2006;306:241–247. doi: 10.1016/j.jmmm.2006.03.069. DOI

Reimer P, Balzer T. Ferucarbotran (Resovist): A new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: Properties, clinical development, and applications. Eur. Radiol. 2003;13:1266–1276. doi: 10.1007/s00330-002-1721-7. PubMed DOI

Alzola-Aldamizetxebarria S, Fernandez-Mendez L, Padro D, Ruiz-Cabello J, Ramos-Cabrer P. A comprehensive introduction to magnetic resonance imaging relaxometry and contrast agents. ACS Omega. 2022;7:36905–36917. doi: 10.1021/acsomega.2c03549. PubMed DOI PMC

Huh YM, et al. In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. J. Am. Chem. Soc. 2005;127:12387–12391. doi: 10.1021/ja052337c. PubMed DOI

Gossuin Y, Gillis P, Hocq A, Vuong QL, Roch A. Magnetic resonance relaxation properties of superparamagnetic particles. Wires Nanomed. Nanobiotechnol. 2009;1:299–310. doi: 10.1002/wnan.36. PubMed DOI